Back to Stakeholders
Care Delivery & Psychedelic FacilitationClinical Care Delivery OrganizationsHealth Systems & Hospitals
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges without Dedicated Psychedelic Research Groups
Care Delivery & Psychedelic FacilitationClinical Care Delivery Organizations
Care Delivery & Psychedelic Facilitation
Research, Drug Development & Manufacturing

University Hospital, Bonn

Germany
10 Trials

University hospital affiliated with the University of Bonn and one of Europe's leading academic medical centers. Its psychiatry and neuroscience departments have contributed to research on psychedelic-assisted therapies and novel treatments for mood and anxiety disorders.

Academic Research

0 papers

Published Papers

0

Trial Involvement

10

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Other
HQ
Germany
Website
Visit

Sponsored Trials

9
Not yet recruitingII

Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder: A Pilot Study (BorderKET)

Start Date
Compounds
Ketamine
Not yet recruitingII

Treatment of Suicidal Ideation in the Emergency Department Using Nitrous Oxide (PROTORISC)

Start Date
Compounds
Placebo, Nitrous Oxide
RecruitingII

Psilocybin for Hospitalized Patients With Treatment-resistant Depression (PSIHOS-D)

Start Date
Compounds
Psilocybin
CompletedNA

Sustained Ketamine Effectiveness for Suicidal Ideation (SKESI)

Start Date
Compounds
Ketamine
Unknown statusNA

Qualitative Study About Psychedelics Using in Psychiatric Disorders (PSYCHEQUALI)

Start Date
RecruitingIV

Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)

Start Date
Compounds
Ketamine, Placebo
CompletedIII

Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks

Start Date
Compounds
Ketamine, Placebo
CompletedIV

Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers

Start Date
Compounds
Ketamine, Placebo
CompletedII, III

Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease

Start Date
Compounds
Ketamine, Placebo

Collaborated Trials

1
RecruitingII

Lysergic Acid Diethylamide (LSD) in Palliative Care (LPC)

Start Date
Compounds
LSD